Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Biomedicines|March 2, 2018
Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor TreatmentAntje Tunger, Maximilian Kießler, Rebekka Wehner, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 26, 2017
Enumeration of WT1-specific CD8+ T cells for clinical application using an MHC Streptamer based no-wash single-platform flow-cytometric assaySarah Matko, Madeleine Teichert, Antje Tunger, et al.
Frontiers in Immunology|March 3, 2020
Bidirectional Crosstalk Between Cancer Stem Cells and Immune Cell SubsetsLuise Müller, Antje Tunger, Ioana Plesca, et al.
Frontiers in Immunology|March 21, 2020
Characteristics of Tumor-Infiltrating Lymphocytes Prior to and During Immune Checkpoint Inhibitor TherapyIoana Plesca, Antje Tunger, Luise Müller, et al.
Frontiers in Cell and Developmental Biology|February 26, 2021
Immunomodulatory Properties of Mesenchymal Stromal Cells: An UpdateLuise Müller, Antje Tunger, Manja Wobus, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 5, 2022
Repeated lipoprotein apheresis and immune response: Effects on different immune cell populationsRomy Walther, Rebekka Wehner, Antje Tunger, et al.
Cancer Letters|February 14, 2013
TLR7/8 agonists trigger immunostimulatory properties of human 6-sulfo LacNAc dendritic cellsHanka Jähnisch, Rebekka Wehner, Antje Tunger, et al.
Journal of Clinical Medicine|September 28, 2019
The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 TherapyAntje Tunger, Ulrich Sommer, Rebekka Wehner, et al.
Pageof 3